Unusual delayed and prolonged arm weakness and atrophy following botulinum toxin injection for musician's cramp: case report.

J Neural Transm (Vienna)

Human Motor Control Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.

Published: February 2025

Botulinum toxin is considered first-line treatment for focal hand dystonia in musicians. Mild, temporary weakness is a common accompaniment of effective injection. We present a unique case of delayed-onset, severe, prolonged weakness and atrophy in a patient with musician's dystonia, successfully treated with botulinum toxin for over 10 years, following injection of his usual muscles at his well-established dose. This pianist received botulinum toxin treatment for more than 10 years, with a stable response. Six weeks after an injection, he developed progressive severe weakness and atrophy of the affected forearm involving both injected and uninjected muscles. Weakness and atrophy took over one year without further injections to resolve. The clinical course and laboratory testing were not suggestive of brachial neuritis, plexopathy, or neuralgic amyotrophy. The literature contains rare case reports of severe weakness and atrophy after botulinum toxin injection, sometimes with delayed onset and sometimes affecting distant muscles. Frequently presenting with pain, such cases often have evidence of plexopathy or neuralgic amyotrophy which were absent in our patient. Clinicians should be aware of this rare potential severe adverse event associated with botulinum toxin.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00702-024-02864-1DOI Listing

Publication Analysis

Top Keywords

botulinum toxin
24
weakness atrophy
20
atrophy botulinum
8
toxin injection
8
severe weakness
8
plexopathy neuralgic
8
neuralgic amyotrophy
8
weakness
6
botulinum
6
toxin
6

Similar Publications

Botulinum neurotoxin (BoNT) is a highly lethal toxin produced by the anaerobic bacterium Clostridium botulinum, which leads to nerve paralysis following poisoning. At present, there is no specific drug officially approved. Antibodies, particularly single-domain antibodies, represent safe and effective candidates for specific drugs against BoNT.

View Article and Find Full Text PDF

A Review on the Expanding Role of Dentists in Facial Esthetics.

J Pharm Bioallied Sci

December 2024

Department of Clinical Dental Sciences, Ajman University, Ajman, United Arab Emirates.

Dentists' role in facial esthetics is growing, with advancements in cosmetic procedures, such as Botox and dermal fillers. Understanding the range of practitioners and their professional backgrounds is crucial for addressing risks. Data collection and analysis was done to retrieve scholarly papers using databases, such as PubMed and advanced Google search, and analyze.

View Article and Find Full Text PDF

Medication and Therapy Profiles for Pain and Symptom Management Among Adults With Cerebral Palsy.

Mayo Clin Proc Innov Qual Outcomes

April 2025

Department of Physical Medicine and Rehabilitation, Michigan Medicine, University of Michigan, Ann Arbor, MI.

Objective: To examine the most common patterns of pain and symptom management strategies among adults living with cerebral palsy (CP), and to determine if there are differences by pain phenotype or co-occurring neurodevelopmental disorders.

Patients And Methods: Federally insured beneficiaries were included if they had an ICD-9-CM/ICD-10-CM diagnosis code for CP (N=41,595). The study took place from January 10, 2024, to December 15, 2024.

View Article and Find Full Text PDF

Ultrasound-Guided Botulinum Toxin Infiltrations in Essential Tremor Patients: A 36-week Follow Up.

Tremor Other Hyperkinet Mov (N Y)

March 2025

Department of Neurology, Consorci Sanitari de Terrassa, Barcelona, Spain.

Background: Essential tremor (ET) presents therapeutic challenges as oral therapies, are often partially effective and carry adverse effects. Deep Brain Stimulation and High-intensity Focused Ultrasound targeting the ventral intermediate thalamic nucleus show efficacy in managing ET; however, their cost and invasiveness deter some patients. Botulinum toxin infiltrations for ET in the upper limbs have been limited by adverse effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!